Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In China

RefinitivLess than 1 min read

Sino Biopharmaceutical Ltd 1177:

TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news